Psychiatric governance, völkisch corporatism, and the German Research Institute 
of Psychiatry in Munich (1912-26). Part 2

Engström, Eric J.; Burgmair, Wolfgang; Weber, Matthias M.

doi:10.1177/0957154X16629579

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Psychiatric governance, völkisch corporatism, and the German Research Institute of Psychiatry in Munich (1912-26). Part 2

MPS-Authors

/persons/resource/persons80319

Engström, Eric J.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80284

Burgmair, Wolfgang
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80579

Weber, Matthias M.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Engström, E. J., Burgmair, W., & Weber, M. M. (2016). Psychiatric governance, völkisch corporatism, and the German Research Institute of Psychiatry in Munich (1912-26). Part 2. HISTORY OF PSYCHIATRY, 27(2), 137-152. doi:10.1177/0957154X16629579.

引用: https://hdl.handle.net/11858/00-001M-0000-002B-9EB1-7

要旨

This is the second of two articles exploring in depth some of the early organizational strategies that were marshalled in efforts to found and develop the German Research Institute of Psychiatry (Deutsche Forschungsanstalt fur Psychiatrie). The first article analysed the strategies of psychiatric governance - best understood as a form of volkisch corporatism - that mobilized a group of stakeholders in the service of higher bio-political and hygienic ends. This second article examines how post-war imperatives and biopolitical agendas shaped the institute's organization and research. It also explores the financial challenges the institute faced amidst the collapse of the German financial system in the early Weimar Republic, including efforts to recruit financial support from the Rockefeller Foundation and other philanthropists in the USA.